<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> is the second most prevalent <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in Germany </plain></SENT>
<SENT sid="1" pm="."><plain>Following the nationwide introduction of the screening colonoscopy at the age of 55 years, more patients are currently diagnosed at an earlier and therefore potential curable stage </plain></SENT>
<SENT sid="2" pm="."><plain>The aim for the coming years will be to further accelerate the acceptance of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> screening </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, the treatment of patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> has become more effective due to interdisciplinary approaches as well as the introduction of new anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> drugs </plain></SENT>
<SENT sid="4" pm="."><plain>The current comprehensive treatment standards were communicated in the form of a guideline in 2008 </plain></SENT>
<SENT sid="5" pm="."><plain>This article will summarise the most important standards for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> screening as well as for treatment and follow-up as a guide for insurance purposes </plain></SENT>
</text></document>